Highly efficacious 5-way protection for time-saving
convenience.A combination of inactivated,
purified, concentrated, adjuvanted, tissue culture origin,
Equine Encephalomyelitis Virus, Eastern and Western, Equine
Herpesvirus EHV-1 and EHV-4, Equine Influenza Virus subtype
A2 including KY 93 strain and Tetanus Toxoid. Intervet serological
data suggest influenza cross protection against certain U.S.
and European strains, including Kentucky 93, 94, 95 and 96,
Suffolk 89, Kildare 89 and 92, Austria 92, Switzerland 93,
New Market 1/93 and 2/93, Berlin 94, Italy 96 and Meath 96.

» More
about Prestige V |
Six-way protection and
time-saving convenience. Protective immunity in a low-volume,
1ml dose.
A combination of inactivated, purified, Concentrated, adjuvanted, tissue
culture origin, Equine Encephalomyelitis Virus, Eastern, Western, and Venezuelan,
Equine Herpesvirus EHV-1 and EHV-4, Equine Influenza Virus subtypes A2 including
KY 93 strain and Tetanus Toxoid. Intervet serological data suggest Influenza
cross protection against certain U.S. and European strains, including Kentucky
93, 94, 95 and 96, Suffolk 89, Kildare 89 and 92, Austria 92, Switzerland
93, New Market 1/93 and 2/93, Berlin 94, Italy 96 and Meath 96.

|
A combination of inactivated, purified, concentrated,
adjuvanted, tissue culture origin, Equine Herpesvirus EHV-1 and
EHV-4 and Equine Influenza Virus subtypes A1 and A2 including
KY 93 strain. Intervet serological data suggest cross protection
against certain U.S. and European strains, including Prague 56,
KY 63, KY 81 and 87, Fountainbleau 79 and Berlin 84 and 89.

» More
about Prestige II |
Equine Rhinopneumonitis Vaccine
A combination of inactivated, purified, concentrated, adjuvanted, equine
tissue culture origin Equine Herpesvirus EHV-1 and EHV-4.

|